Stress and mood of adults with moyamoya disease: A cross‐sectional study

Yang, Yong Sook; Ryu, Gi Wook; Yeom, Insun; Shim, Kyu Won; Choi, Mona

doi:10.1111/nhs.12729

Cited by 5 publications

(7 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This finding is in accordance with the results of a study on the Dutch version of the PsyMate, which presented sensitivity to the change of mood over time and applicability for patients in an ambulatory mental health setting in the Netherlands [ 25 ]. The poor ICCs may reflect the dynamics of affect fluctuating and changing over time [ 41 ] and the variability in the anxious and depressive mood of patients with MMD [ 7 , 42 ].…”

Section: Discussionmentioning

confidence: 99%

Psychometric Properties of the Korean Version of the PsyMate Scale Using a Smartphone App: Ecological Momentary Assessment Study

Yang¹,

Ryu²,

Delespaul³

et al. 2020

JMIR Mhealth Uhealth

Self Cite

View full text Add to dashboard Cite

Background Ecological momentary assessment (EMA) is a method for capturing the changes in the variables in daily life with increased accuracy and decreased recall bias. The PsyMate scale assesses momentary moods in daily life and can be used in various settings. Objective The aim of this study was to develop a Korean version of the PsyMate (K-PsyMate) scale and evaluate its psychometric properties by using the EMA method in patients with moyamoya disease (MMD) in South Korea. Methods Patients with MMD aged over 18 years were recruited from July 2018 to January 2019 at the inpatient and outpatient departments of a university hospital in South Korea. The K-PsyMate scale comprising 13 items was developed following a translation/back translation approach of the English version and loaded onto a mobile app. Participants were instructed to enter their moods 4 times a day for 7 consecutive days. Content validity index, factor analysis, and Pearson’s correlation were performed for validity analysis. For reliability, intraclass correlation coefficients between the first and last measurements were estimated by mean rating, absolute agreement, and a 2-way mixed-effects model. Usability was analyzed through a descriptive analysis, 2-tailed t test, and analysis of variance, and the results were confirmed by Mann-Whitney U test and the Kruskal-Wallis test, as the dependent variable was not normally distributed. Results In total, 1929 assessments from 93 patients were analyzed. The mean age of the participants was 40.59 (SD 10.06) years, and 66 (71%) of the 93 participants were women. Content validity was excellent as content validity index was 0.99, and 2 factors, negative affect and positive affect, were derived by an exploratory factor analysis. The correlations between the subdomains of the K-PsyMate scale and Hospital Anxiety and Depression Scale were significant (P<.001). The agreement between the first and last measurements was poor to moderate according to the obtained intraclass correlation coefficient values. Usability was evaluated by 67 (72%) out of the 93 participants. The participants rated the accuracy of assessing their momentary moods on the app at 4.13 (SD 0.97), easiness in understanding questions, operating, and inputting answers at 4.12 (SD 0.88), and interruption by the survey alarms at 2.48 (SD 1.02) out of 5. Conclusions The K-PsyMate scale has good validity but poor to moderate agreement, which reflects the characteristics of the EMA data collected in real and natural living environments without control. The findings of our study show that the K-PsyMate scale uploaded in a mobile app can be a valid and reliable tool for evaluating the momentary mood of patients with MMD because using a mobile app is convenient and patients are familiar with their own smartphones, which they use in their daily lives.

show abstract

Section: Discussionmentioning

confidence: 99%

Psychometric Properties of the Korean Version of the PsyMate Scale Using a Smartphone App: Ecological Momentary Assessment Study

Yang¹,

Ryu²,

Delespaul³

et al. 2020

JMIR Mhealth Uhealth

Self Cite

View full text Add to dashboard Cite

show abstract

“… 4 Finally, MMD may present with neuropsychiatric symptoms such as mood change, anxiety, and depression. 10 …”

Section: Natural History and Neuropsychiatric Manifestations Of Moyam...mentioning

confidence: 99%

“…However, after the initial period of cognitive decline, MMD patients’ cognitive function remains relatively stable long-term regardless of their stroke history. 11 A cross-sectional study 10 found that Korean MMD patients had higher levels of anxiety and depression than Korean and Dutch patients who previously had strokes and German patients with unruptured aneurysms. MMD patients within one year of diagnosis experience greater depression than patients diagnosed for one year or more.…”

Section: Neuropsychiatric Manifestations Of Moyamoya Diseasementioning

confidence: 99%

Current Understanding of Moyamoya Disease (MMD) and Associated Neuropsychiatric Outcomes

Antonov,

Terraciano,

Essibayi

et al. 2023

NDT

View full text Add to dashboard Cite

Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by the progressive narrowing and occlusion of the intracranial internal carotid arteries, leading to the formation of abnormal collateral vessels. MMD primarily affects the cerebrovascular system, and evidence suggests it is associated with various neuropsychiatric outcomes. This manuscript aims to provide an overview of the current understanding of MMD, including its epidemiology, pathophysiology, clinical manifestations, and diagnosis. Furthermore, it explores the emerging research on the neuropsychiatric sequelae of MMD, such as cognitive impairment, psychiatric disorders, and quality of life. The manuscript concludes with the challenges in managing MMD-related neuropsychiatric outcomes and potential avenues for future research.

show abstract

“…A systematic review [14] showed that the incidence rate of cognitive impairment in MMD was approximately 30%, with moderate to severe disturbance across varied cognitive domains. Although psychiatric changes are usually not onset symptoms, recent cross-sectional studies [15,16] found that depression, anxiety, and posttraumatic stress syndrome were common complications in MMD survivors and were correlated with neurological impairment [15]. Hippocampus atrophy is regarded as an imaging hallmark of dementia and is seen in a variety of neurodegenerative diseases and poststroke dementia patients [17].…”

Section: Introductionmentioning

confidence: 99%

Atrophy in subcortical gray matter in adult patients with moyamoya disease

Zuo¹,

Guo²,

Chen³

et al. 2023

Neurol Sci

View full text Add to dashboard Cite

Background Acute cerebrovascular accidents, long-term hypoperfusion, and/or remote neuronal degeneration may lead to structural alterations in patients with moyamoya disease (MMD). This study sought to comprehensively investigate the distribution characteristics of subcortical gray matter volume and their correlations with angiographic changes in the intracranial artery in patients with MMD. Method One hundred forty-two patients with MMD and 142 age- and sex-matched healthy controls underwent 3-dimensional high-resolution structural magnetic resonance imaging. Volumes of subcortical gray matter and subregions of the hippocampus and amygdala were calculated, and the degree of stenosis/occlusion of intracranial arteries in patients with MMD was evaluated on MR angiography. Results Volume reductions in the thalamus, caudate, putamen, hippocampus, amygdala, pallidum, and nucleus accumbens were found in patients with MMD. Hippocampal subfields and amygdala subnuclei in patients with MMD showed distinct vulnerability, and morphological alterations in specific subregions were more obvious than in the whole hippocampus/amygdala. Volume loss in several subcortical areas was related to disease duration and intracranial arterial changes. Conclusions Our findings revealed structural alteration patterns of subcortical gray matter in MMD. The specific atrophy in subregions of the hippocampus and the amygdala suggested potential cognitive and affective impairments in MMD, which warrants further investigation. Chronic cerebral hemodynamic alterations in MMD may play a pivotal role in morphological changes in subcortical areas.

show abstract

Stress and mood of adults with moyamoya disease: A cross‐sectional study

Cited by 5 publications

References 43 publications

Psychometric Properties of the Korean Version of the PsyMate Scale Using a Smartphone App: Ecological Momentary Assessment Study

Psychometric Properties of the Korean Version of the PsyMate Scale Using a Smartphone App: Ecological Momentary Assessment Study

Current Understanding of Moyamoya Disease (MMD) and Associated Neuropsychiatric Outcomes

Atrophy in subcortical gray matter in adult patients with moyamoya disease

Contact Info

Product

Resources

About